D., West Virginia University Hospitals, Morgantown, West Virginia MELANIE A. Part II, “Vaginal Infections, Pelvic Inflammatory Disease and Genital Warts,” will appear in the next issue of In 1998, the Centers for Disease Control and Prevention released guidelines for the treatment of sexually transmitted diseases. SC., West Virginia University, Morgantown, West Virginia Am Fam Physician. This is Part I of a two-part article on drug treatment of common sexually transmitted diseases. Several treatment advances have been made since the previous guidelines were published. Part I of this two-part article describes current recommendations for the treatment of genital ulcer diseases, urethritis and cervicitis. Treatment advances include effective single-dose regimens for many sexually transmitted diseases and improved therapies for herpes infections. Two single-dose regimens, 1 g of oral azithromycin and 250 mg of intramuscular ceftriaxone, are effective for the treatment of chancroid. A three-day course of 500 mg of oral ciprofloxacin twice daily may be used to treat chancroid in patients who are not pregnant. Researchers from UCLA have developed a laboratory test that helps physicians determine which people with gonorrhea may be more treatable with an antibiotic that has not been recommended since 2007 because of concerns that the resistance to the drug was growing. Gonorrhea has developed increasing resistance to all current antibiotics. Due to the spread of multi-drug resistant gonorrhea, health authorities have declared it one of the top-three urgent threats to public health. Ciprofloxacin was used to combat the sexually transmitted infection until 2007, when the Centers for Disease Control and Prevention stopped recommending its use after gonococcal infections developed resistance to it. Nevertheless, about 80 percent of gonorrhea infections in the United States, however, could be treated with ciprofloxacin. Scientists have been trying to determine how to better identify cases for targeted use of ciprofloxacin therapy, reducing the need to use the antibiotic ceftriaxone and risking increased resistance to that drug. Gonorrhea's resistance rate to ceftriaxone is currently less than 1 percent.
Gonorrhea is a sexually transmitted disease get it from having sex with someone who is infected with it. Some people call it “the clap.” Gonorrhea usually causes pain and other symptoms. Sex Transm Dis. 1994 Nov-Dec;216345-52. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea a worldwide summary. Echols RM1.